Hyperkalaemia Prevalence, Recurrence and Treatment in Haemodialysis

CompletedOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

May 17, 2021

Primary Completion Date

July 18, 2022

Study Completion Date

July 18, 2022

Conditions
HyperkalemiaHemodialysisWater-Electrolyte Imbalance
Interventions
OTHER

observational study

no study drug involved, observational study.

Trial Locations (12)

2000127

Research Site, Shanghai

Unknown

Research Site, Beijing

Research Site, Guangzhou

Research Site, Shenzhen

Research Site, Shijiazhuang

Research Site, Taihe

Research Site, Nanchang

Research Site, Shenyang

Research Site, Taiyuan

Research Site, Yangquan

Research Site, Ningbo

Research Site, Wenzhou

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY